slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES PowerPoint Presentation
Download Presentation
A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES

Loading in 2 Seconds...

play fullscreen
1 / 23

A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES - PowerPoint PPT Presentation


  • 124 Views
  • Uploaded on

3,700 employees in the world Over 5,000 hospitals served around the world One million patients treated with Sorin Group’s devices every year in over 80 countries Listed on the Milan Stock Exchange. A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES' - damon


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
a global medical device company and a leader in the treatment of cardiovascular diseases
3,700 employees in the world

Over 5,000 hospitals served around the world

One million patients treated with Sorin Group’s devices every year in over 80 countries

Listed on the Milan Stock Exchange

A GLOBAL MEDICAL DEVICE COMPANY AND A LEADER IN THE TREATMENT OF CARDIOVASCULAR DISEASES
slide3

A GLOBAL REACH

  • Focusing on 3 core Business Units
  • The World Leader in Cardiopulmonary with a 35% market share worldwide
  • A strong presence in Europe and in Japan in the Cardiac Rhythm Management market
  • #2 Heart Valve Company in Europe
slide4

SORIN GROUP SALESBY THERAPEUTIC AREA - 2010

HEARTVALVES

  • €120.5 millionTissue and mechanical valves, annuloplasty rings for heart valve replacement and repair

16%

CARDIOPULMONARY

  • € 338 millionHeart-lung machines, oxygenators, autotransfusion systems when extracorporeal circulation is needed during prosthetic replacement, bypass, valve repair

46%

€ 746 million

38%

CARDIAC RHYTHM

MANAGEMENT (CRM)

  • €285 millionImplantable cardiac defibrillator (ICD) and pacemaker systems to restore normal cardiac rhythm, cardiac resynchronization therapy (CRT) systems to treat heart failure and Holter systems
slide5

SORIN GROUPFOUNDED IN 1956 AS A JOINT VENTURE RESEARCH PROJECT

SORIN

MANUFACTURING FACILITIES

FIAT

Automotive manufacturer

(Turin)

  • In The 60s

MONTECATINI

  • Today

Chemical company

(Milan)

slide6

MAJOR MILESTONES (1)

LISTING ON

MILAN STOCK EXCHANGE

ENTERING

SORIN GROUP

COMPANIES

FOUNDATION

40’s 70’s

80’s

’92

’99

’01

’03

January 2004

Sorin Biomedica

Stöckert / Dideco

Cobe Cardiovascular

ELA Medical

Carbomedics

slide7

RECENT MILESTONES (2)

EXPANDING PRODUCT PORTFOLIO

STREAMLINING

ORGANIZATION

FOCUSING ON

CORE ACTIVITIES

DISTRIBUTOR ACQUISITIONS

2011

2010

2009

2011

ACQUISITIONS

2008

DIVESTITURES

EVH

(Endoscopic Vessel

Harvesting)

Vascular Therapy

Austria

Renal Care

Netherlands

Gish

(Oxygenators)

Angel™

(Whole Blood Separation System)

Poland

slide8

A PORTFOLIO OF INNOVATIVE PRODUCTS

Heart-Lung Machines

Oxygenators

Autotransfusion Systems

CARDIOPULMONARY

Heart failure

Management Systems

Tachyarrhythmia

Management Systems

Bradyarrhythmia

Management Systems

CARDIAC RHYTHM MANAGEMENT (CRM)

Tissue Valves

Mechanical Valves

Self-Anchoring, Sutureless Valve

HEARTVALVES

slide9

A TRADITION OF EXCELLENCE IN INNOVATION

  • EUR 66.9 million dedicated to R&D i.e. 9% of sales revenues
  • 14% of employees work in R&D Over 500 people in North America, France, Italy and Germany
  • Numerous partnerships with cardiology specialists and cardiac surgeons as well as world-renowned universities and research centers
  • Relying on “engineer-physician intelligence networks” to develop innovative therapeutic solutions
  • A portfolio of 2,200 patents
slide10

40 YEARSOF BREAKTHROUGHS & HISTORIC FIRSTS

2011

2010

2008

2006

2002

1998

1995

1994

1993

1982

1981

1973

  • Launch of the FIRST Self-Anchoring & Sutureless Heart Valve : PERCEVAL S ™
  • XTRA New Sorin Group Autrotransfusion machine
  • World’s FIRST CRT-D with hemodynamic sensors: PARADYM™
  • FIRST semi rigid ring with unique 3D motion (Memo 3D™)
  • First oxygenator with integrated arterial filter – SORIN* Synthesis™
  • World’s FIRST sensor to optimize patient hemodynamics
  • First dual chamber adult oxygenator – DIDECO* Avant™
  • World’s FIRST dual-chamber ICD implant: ELA Medical* DEFENDER™
  • World’s FIRST implant of a bi-ventricular pacing system (ELA Medical)
  • First newborn oxygenator – DIDECO Lilliput™
  • FIRST implant of a biological stented heart valve (MITROFLOW*™)
  • World’s FIRST microcomputer within an ELA Medical’s pacemaker
  • FIRST modular heart lung machine by STOECKERT*

* These companies were gradually merged to build the strong unified brand that Sorin Group represents today

slide11

RoW

15%

15%

Japan

9%

9%

48%

Europe

48%

€746 million

NorthAmerica

28%

28%

A GLOBAL PRESENCE

Current R&D and Manufacturing Locations

Sales By Geography

CARDIAC RHYTHM MANAGEMENT (CRM)

CARDIOPULMONARY

HEARTVALVES

Mirandola (Italy)

Munich (Germany)

Denver (USA)

Clamart (France)

Minneapolis (USA)

Meylan (France)

Saluggia (Italy)

Vancouver (Canada)

slide12

TECHNOLOGICAL LEADERSHIP - SOME EXAMPLES

PROJECT

HIGHLIGHTS

LinOx

(Leadership in Oxygenation)

Technological and

industrial innovation

CARDIOPULMONARY

Remote

Monitoring

First pilot

system trial

CARDIAC RHYTHM MANAGEMENT

Perceval STM

Self-Anchoring

Sutureless Heart Valve

HEARTVALVES

Strong customer

Support (surgeons)

slide13

EXECUTIVE LEADERSHIP TEAM

André-Michel BALLESTERChief Executive Officer

Davide BIANCHI

Heart Valves

Stefano DI LULLO

Cardiac Rhythm Management

Michel DARNAUD

Cardiopulmonary

& Intercontinental

Kieran TUITE

Corporate Operations

Edward ANDRLE

Strategy

& Business Development

Brian SHERIDANLegal

Stéphane BESSETTE

Human Resources

& Communication

Demetrio MAURO Finance & IT

slide14

SORIN GROUP VISION

  • A global leader innovating in the attractive €20 billion Cardiovascular Market
  • The market leader in Cardiopulmonary
  • A growing player in the Heart Valves and Cardiac Rhythm Management arenas, with a strong European franchise
  • A company with a multi-cultural management team and a simplified organization

WE ARE…

  • Continue to invest in technological innovation, for sustainable, profitable long-term growth

WE WILL…

cos perceval s
Cos’è Perceval S?

Perceval è un sistema innovativo per il trattamento della stenosi aortica.

Sorin Group propone al cardiochirurgo:

  • Innovazione
  • Una nuova terapia
  • Un nuovo sistema curativo
slide16

ValvoladiPericardioBovino

  • Disegno a doppiofogliodipericardio con
  • >20 annidiesperienza
  • Fissaggio del tessuto
  • Trattamentodetossificante
  • Dispositivo di ancoraggio
  • Lega auto-espandibile
  • Geometria “Double ring”
  • Design speciale del supporto
  • Ricoperto di Carbofilm

Perceval S: Progettata attorno ad una valvola comprovata

PERCEVAL S

16

slide17

Perceval S: piattaforma provata clinicamente

Valvola in Pericardio Bovino

> 20 ANNI DI ESPERIENZA

• Disegno valvola

- doppio foglio di Pericardio

- cross stitches

- Performance eccellenti

Tessuto Valvola

- Pericardio Bovino

- detossificazione

  • Dispositivo di Ancoraggio
  • Disegno speciale Montanti
  • Geometria a doppio anello
  • Lega ad auto Espansione
  • Rivestimento in Carbofilm
slide18

Componente Pericardica :

Struttura a Doppio Foglio

La configurazione finale è ottenuta da un unico foglio composto da due: un foglio di pericardio a forma di tricuspide è suturato ad un secondo usando fili rivestiti di Carbonio turbostratico(CarbofilmTM).

Foglio Funzionale interno

Foglio interno Funzionale

Foglio esterno di supporto

Beneficio: apertura cilindrica con bassi gradienti pressori e meno turbolenze

slide19

Il dispositivo di ancoraggio:

Sistema Auto-Ancorante

Anello outflow smussato

ANELLO OUTFLOW

(Livello giunzione

Sinotubulare)

Montanti Sinusoidali

(Seni di Valsalva)

Montanti commissurali

IANELLO INFLOW RING

(Livello annulare)

slide20

Il dispositivo di ancoraggio:

Montanti Auto-Ancoranti

Supporto alla Valvola

Montanti Commissurali

Montanti Sinusoidali

  • Ancoraggio
  • Adatta con diverse anatomie del seno di Valsalva , no lrigurgiti paravalvolari
  • Previene Migrazioni

Lega auto-espansione

Adattamento alla Radice Aortica

Beneficio: auto-ancorante, stabile, senza suture

slide21

Il dispositivo di ancoraggio :Carbofilm

Physical Vapour Deposition

High Vacuum Chamber

(room temperature)

Electric Field

spessore

0.5µm

Beneficio: Carbofilm ottimizza emocompatibilità e biocompatibilità

perceval s
Perceval S
  • Impiantata con Tecnica Chirurgica Standard a cuore aperto
  • Adatta per MICS
  • Pericardio Bovino per performance di durata ed emodinamica
  • Derivata da esperienza 20 anni Tecnologia Pericarbon Freedom Sorin
  • Tecnologia Lega Superelastica ad Auto – Espansione
  • Curativa –rimozione valvola calcifica
  • Anatomica –adatta all’anatomia del paziente
  • Senza fili di sutura
  • Collassabile
  • Reduce tempi di X-clamping & procedurali
  • Eccellente performance Emodinamica
slide23

Sorin S.p.A.

Via Benigno Crespi, 17

20159 Milano – Italy

www.sorin.com